These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 36071523)

  • 41. Correlation analysis of m6A-modified regulators with immune microenvironment infiltrating cells in lung adenocarcinoma.
    Ye W; Huang T
    PLoS One; 2022; 17(2):e0264384. PubMed ID: 35196365
    [TBL] [Abstract][Full Text] [Related]  

  • 42. N6-methyladenosine Regulator-Mediated Immune Genes Identify Breast Cancer Immune Subtypes and Predict Immunotherapy Efficacy.
    Zhang MM; Lin YL; Zeng WF; Li Y; Yang Y; Liu M; Ye YJ; Jiang KW; Wang S; Wang S
    Front Genet; 2021; 12():790888. PubMed ID: 34976022
    [TBL] [Abstract][Full Text] [Related]  

  • 43. RNA N6-Methyladenosine Regulator-Mediated Methylation Modifications Pattern and Immune Infiltration Features in Glioblastoma.
    Pan Y; Xiao K; Li Y; Li Y; Liu Q
    Front Oncol; 2021; 11():632934. PubMed ID: 33718217
    [TBL] [Abstract][Full Text] [Related]  

  • 44. RNA and RNA Derivatives: Light and Dark Sides in Cancer Immunotherapy.
    Deng Y; Xiao M; Wan AH; Li J; Sun L; Liang H; Wang QP; Yin S; Bu X; Wan G
    Antioxid Redox Signal; 2022 Dec; 37(16-18):1266-1290. PubMed ID: 35369726
    [No Abstract]   [Full Text] [Related]  

  • 45. N
    Liu Z; Wang T; She Y; Wu K; Gu S; Li L; Dong C; Chen C; Zhou Y
    Mol Cancer; 2021 Aug; 20(1):105. PubMed ID: 34416901
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Significance of N6-Methyladenosine RNA Methylation Regulators in Immune Infiltrates of Ovarian Cancer.
    Gu J; Bi F
    Front Genet; 2021; 12():671179. PubMed ID: 34306015
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comprehensive Analysis of m6A RNA Methylation Regulators and the Immune Microenvironment to Aid Immunotherapy in Pancreatic Cancer.
    Guo Y; Wang R; Li J; Song Y; Min J; Zhao T; Hua L; Shi J; Zhang C; Ma P; Yang C; Zhu L; Gan D; Li S; Liu X; Su H
    Front Immunol; 2021; 12():769425. PubMed ID: 34804059
    [TBL] [Abstract][Full Text] [Related]  

  • 48. m6A Regulator-Mediated Methylation Modification Patterns and Tumor Microenvironment Infiltration Characterization in Acute Myeloid Leukemia.
    Du A; Wu X; Gao Y; Jiang B; Wang J; Zhang P; Zhao Q
    Front Immunol; 2021; 12():789914. PubMed ID: 34887874
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Integrative Analysis of m6A RNA Methylation Regulators and the Tumor Immune Microenvironment in Non-Small-Cell Lung Cancer.
    Zhu J; Jiang Y; Wang T; Wu A; Zhou T; Zhang A; Tang Y; Shen Z; Wang J; Zhou H; Shi J; Chen J
    Dis Markers; 2022; 2022():2989200. PubMed ID: 35186164
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epigenetic N6-methyladenosine modification of RNA and DNA regulates cancer.
    Liang Z; Kidwell RL; Deng H; Xie Q
    Cancer Biol Med; 2020 Feb; 17(1):9-19. PubMed ID: 32296573
    [TBL] [Abstract][Full Text] [Related]  

  • 51. RNA m
    Han Z; Yi X; Li J; Zhang T; Liao D; You J; Ai J
    Biochim Biophys Acta Rev Cancer; 2023 Sep; 1878(5):188961. PubMed ID: 37507057
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The evolving landscape of N
    Gu Y; Wu X; Zhang J; Fang Y; Pan Y; Shu Y; Ma P
    Mol Ther; 2021 May; 29(5):1703-1715. PubMed ID: 33839323
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The N6-methyladenosine:mechanisms, diagnostic value, immunotherapy prospec-ts and challenges in gastric cancer.
    Wu W; Zhang F; Zhao J; He P; Li Y
    Exp Cell Res; 2022 Jun; 415(2):113115. PubMed ID: 35341774
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analysis of m6A-Related Signatures in the Tumor Immune Microenvironment and Identification of Clinical Prognostic Regulators in Adrenocortical Carcinoma.
    Jin Y; Wang Z; He D; Zhu Y; Hu X; Gong L; Xiao M; Chen X; Cheng Y; Cao K
    Front Immunol; 2021; 12():637933. PubMed ID: 33746977
    [TBL] [Abstract][Full Text] [Related]  

  • 55. N6-Methyladenosine-Related LncRNAs Are Potential Remodeling Indicators in the Tumor Microenvironment and Prognostic Markers in Osteosarcoma.
    Wu Z; Zhang X; Chen D; Li Z; Wu X; Wang J; Deng Y
    Front Immunol; 2021; 12():806189. PubMed ID: 35095893
    [TBL] [Abstract][Full Text] [Related]  

  • 56. N6-Methyladenosine-Related lncRNAs as potential biomarkers for predicting prognoses and immune responses in patients with cervical cancer.
    Zhang H; Kong W; Zhao X; Han C; Liu T; Li J; Song D
    BMC Genom Data; 2022 Jan; 23(1):8. PubMed ID: 35042477
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Non-N
    Xu J; Gao Z; Liu K; Fan Y; Zhang Z; Xue H; Guo X; Zhang P; Deng L; Wang S; Wang H; Wang Q; Zhao R; Li G
    Front Immunol; 2021; 12():809808. PubMed ID: 35154083
    [TBL] [Abstract][Full Text] [Related]  

  • 58. m6A Regulators Mediated Methylation Modification Patterns and Tumor Microenvironment Infiltration Characterization In Nasopharyngeal Carcinoma.
    Liu Z; He J; Han J; Yang J; Liao W; Chen N
    Front Immunol; 2021; 12():762243. PubMed ID: 35069534
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Insights into N6-methyladenosine and programmed cell death in cancer.
    Liu L; Li H; Hu D; Wang Y; Shao W; Zhong J; Yang S; Liu J; Zhang J
    Mol Cancer; 2022 Jan; 21(1):32. PubMed ID: 35090469
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Novel Insights Into the Role of N6-Methyladenosine RNA Modification in Bone Pathophysiology.
    Chen J; Tian Y; Zhang Q; Ren D; Zhang Q; Yan X; Wang L; He Z; Zhang W; Zhang T; Yuan X
    Stem Cells Dev; 2021 Jan; 30(1):17-28. PubMed ID: 33231507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.